The BD BodyGuard™ infusion pumps specified allow for access through the RS-232 (serial) port interface. If exploited, threat actors with physical access, specialized equipment and knowledge may be able to configure or disable the pump. No electronic protected health information (ePHI), protected health information (PHI) or personally identifiable information (PII) is stored in the pump.
Published 2022-12-05 22:15:11
Updated 2023-10-27 21:15:08
View at NVD,   CVE.org
Vulnerability category: BypassGain privilege

Exploit prediction scoring system (EPSS) score for CVE-2022-43557

0.05%
Probability of exploitation activity in the next 30 days EPSS Score History
~ 17 %
Percentile, the proportion of vulnerabilities that are scored at or less

CVSS scores for CVE-2022-43557

Base Score Base Severity CVSS Vector Exploitability Score Impact Score Score Source First Seen
5.3
MEDIUM CVSS:3.1/AV:P/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:H
0.5
4.7
Becton, Dickinson and Company (BD)
5.3
MEDIUM CVSS:3.1/AV:P/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:H
0.5
4.7
NIST

CWE ids for CVE-2022-43557

  • When an actor claims to have a given identity, the product does not prove or insufficiently proves that the claim is correct.
    Assigned by: nvd@nist.gov (Primary)
  • The lack of protections on alternate paths to access control-protected assets (such as unprotected shadow registers and other external facing unguarded interfaces) allows an attacker to bypass existing protections to the asset that are only performed against the primary path.
    Assigned by: cybersecurity@bd.com (Secondary)

References for CVE-2022-43557

Products affected by CVE-2022-43557

This web site uses cookies for managing your session, storing preferences, website analytics and additional purposes described in our privacy policy.
By using this web site you are agreeing to CVEdetails.com terms of use!